A metabolite of L-tyrosine and L-phenylalanine
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Fumarylacetoacetic Acid

Item No. 46207

Technical Information
Formal Name
4,6-dioxo-2E-octenedioic acid
CAS Number
28613-33-4
Synonyms
  • 4-Fumarylacetoacetic Acid
Molecular Formula
C8H8O6
Formula Weight
Purity
≥95%
A solid
SMILES
OC(/C=C/C(CC(CC(O)=O)=O)=O)=O
InChi Code
InChI=1S/C8H8O6/c9-5(1-2-7(11)12)3-6(10)4-8(13)14/h1-2H,3-4H2,(H,11,12)(H,13,14)/b2-1+
InChi Key
GACSIVHAIFQKTC-OWOJBTEDSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Fumarylacetoacetic acid is a metabolite of L-tyrosine (Item No. 36333) and L-phenylalanine (Item No. 31498).1,2,3 It is enzymatically formed from L-tyrosine via 4-hydroxyphenylpyruvic acid (Item No. 38508), homogentisate (Item No. 20045), and 4-maleylacetoacetate intermediates. Fumarylacetoacetic acid inhibits DNA glycosylation, the initial step in base excision repair, in a cell-free assay.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ravdin, R.G., and Crandall, D.I. The enzymatic conversion of homogentisic acid to 4-fumarylacetoacetic acid. The Journal of Biological Chemisty 189(1), 137-149 (1951).

    2. Bliksrud, Y.T., Ellingsen, A., and Bjørås, M. Fumarylacetoacetate inhibits the initial step of the base excision repair pathway: Implication for the pathogenesis of tyrosinemia type I. J. Inherit. Metab. Dis. 36(5), 773-778 (2013).

    3. Grasso, D., Balloni, V., Baratto, M.C., et al. Ochronotic deposition in alkaptonuria: Semiquinone-mediated oxidative coupling and metabolic drivers of homogentisic acid accumulation. Int. J. Mol. Sci. 26(19), 9674 (2025).